CTKB — Cytek Biosciences, Inc. stock price, charts and financials

QT44Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.28
-0.03-0.70%
OverviewShort InterestFilings
CTKBQT44Cytek Biosciences, Inc.·NASDAQ
4.28-0.70%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 15, 20268-KCurrent report
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 30, 20263Initial statement of beneficial ownership
Jun 25, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 16, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20263Initial statement of beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
Jun 01, 2026SDSpecialized disclosure report
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 18, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
#1 / 25 of 421
Page
▼
/ 17